Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
ImmunityBio, Inc.
GERCOR - Multidisciplinary Oncology Cooperative Group
UNICANCER
Fate Therapeutics